CARGO Therapeutics, Inc. (CRGX)
(Delayed Data from NSDQ)
$17.85 USD
+0.15 (0.85%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $18.15 +0.30 (1.68%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRGX 17.85 +0.15(0.85%)
Will CRGX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CRGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRGX
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
CRGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Mar 25, 2024
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
Alexandria (ARE) Inks Leases at its Campuses Amid Solid Demand
Other News for CRGX
Cargo Therapeutics initiated with bullish view at H.C. Wainwright, here's why
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
CARGO Therapeutics’ Promising Pipeline and Market Potential Justify Buy Rating
Cargo Therapeutics initiated with bullish view at Piper Sandler, here's why
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director